By using in vivo and in vitro models, we show for the first time that HMGB1 induces inflammatory reactions in tendon cells and tendon matrix, a hallmark of early stages of tendinopathy, and injection of HMGB1 inhibitor, GL, abolishes the development of tendinopathy. The gene discussed is HMGB1; the disease is disease of the tendon.